Trump deals with Lilly, Novo Nordisk could broaden obesity drug access

0 Comments

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. 6, 2025. Andrew Caballero-Reynolds | AFP | Getty Images President Donald Trump on Thursday struck landmark deals with Eli Lilly and Novo Nordisk that could mark a turning point in how many people can access […]


What’s next for the weight loss drug market: pills, rivals, insurance

0 Comments

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]


Eli Lilly’s obesity pill will rival Novo Nordisk’s oral Wegovy drug

0 Comments

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial, […]


Trump most favored nations drug price executive order: What to know

0 Comments

President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S. […]


Biotech mogul Sam Waksal of Martha Stewart fame accused of testing illegal ‘swine drug’ on child

0 Comments

Biotech mogul Sam Waksal – who landed in prison two decades ago over the ImClone insider trading scandal that also resulted in jail time for Martha Stewart – allegedly tested an illegal “swine drug” treatment on a child with epilepsy, according to a bombshell lawsuit. Waksal, who is not a medical doctor, imported the veterinary […]


FDA Layoffs Could Raise Drug Costs and Erode Food Safety

0 Comments

Health Secretary Robert F. Kennedy Jr. announced wide-ranging cutbacks at federal health agencies, including the Food and Drug Administration, that would eliminate duplicative services and paper pushers. But in interviews with more than a dozen current and former F.D.A. staff members, a different picture emerged of the far-reaching effects of the layoffs that would ultimately […]


Trump tariffs could raise drug costs, worsen shortages

0 Comments

Shana Novak | Stone | Getty Images President Donald Trump’s steep tariffs on Canada, Mexico and China could worsen ex­ist­ing drug shortages in the U.S., raise health-care costs for patients and threaten cash-strapped generic drugmakers, some drug trade groups warn. Trump on Saturday announced he would impose a 25% tariff on nearly all goods shipped […]


FDA approves Vertex non-opioid painkiller drug Journavx

0 Comments

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston. Brian Snyder | Reuters The Food and Drug Administration on Thursday approved Vertex Pharmaceuticals’ non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction.  Vertex is now the first drugmaker in decades to gain U.S. […]


Trump Pardons Ross Ulbricht, Creator of Silk Road Drug Marketplace

0 Comments

President Trump on Tuesday granted a pardon to Ross Ulbricht, the creator of the Silk Road drug marketplace and a cult hero in the cryptocurrency and libertarian worlds. In doing so, Mr. Trump fulfilled a promise that he made repeatedly on the campaign trail as he courted political contributions from the crypto industry, which spent […]


Medicare drug price negotiations list includes Ozempic

0 Comments

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating Type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, March 29, 2023. George Frey | Reuters The Biden administration on Friday unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and […]